Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
    Datensatz exportieren als...
  • BibTeX
Cost-effectiveness analysis (CEA) of seven treatment regimens in metastatic hormone-sensitive prostate cancer (mHSPC): A public payer perspective using network meta-analysis
Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5081-5081
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Cost-effectiveness analysis of seven treatment regimens in metastatic hormone-sensitive prostate cancer (mHSPC): A public payer perspective using network meta-analysis
Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.268-268
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Journal of clinical oncology, 2018-04, Vol.36 (11), p.1080-1087
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Closing the gap in health care disparities by improving the rate of lung cancer screening in an intercity hospital
Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.195-195
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Nomogram to predict peritoneal dissemination in gastric cancer
Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.465-465
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A VA Federal Supply Schedule (VAFSS)–based cost-effectiveness analysis of immunotherapy-tyrosine kinase inhibitor (IO-TKI) regimens and sunitinib in the treatment of metastatic renal cell carcinoma (mRCC)
Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.312-312
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216)
Journal of clinical oncology, 2022-10, Vol.40 (28), p.3301-3309
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Examination of real-world data from geriatric assessments in a comprehensive cancer center to explore predominant and cancer-specific domains for intervention
Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e24027-e24027
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Homologous recombination repair (HRR) mutation concordance between liquid biopsy (LB) and tumor tissue by NGS in a real-world prostate cancer (PC) database
Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.260-260
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A randomized phase II study of apalutamide with or without carotuximab (ant-CD105) in metastatic, castration-resistant prostate cancer
Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS5107-TPS5107
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Investigating documented reasons for withdrawal from clinical trials for patients with advanced prostate cancer (PCa)
Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.105-105
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Assessment of serial serum chromogranin A (CGA) and CGA/PSA ratio and treatment response with abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC)
Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e17036-e17036
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer: are there implications for blood pressure management in patients receiving chemotherapy?
Journal of clinical oncology, 2006-05, Vol.24 (15), p.2399; author reply 2399-2399
2006
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Impact of synchronous (sync) vs metachronous (meta) metastasis at the presentation on survival in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with androgen receptor signaling inhibitors (ARSIs)
Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5049-5049
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Alliance A031902 (CASPAR): A randomized phase (ph) 3 trial of enzalutamide with rucaparib/placebo in first-line metastatic castration-resistant prostate cancer (mCRPC)
Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.TPS277-TPS277
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Plasma proteome landscape and impact of the circulatory proteome on clinical outcomes in metastatic prostate cancer
Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.237-237
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Association of whole blood mRNA expression and overall survival (OS) in metastatic castrate resistant prostate cancer (mCRPC)
Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.201-201
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A phase II study of rucaparib monotherapy in nonmetastatic, hormone-sensitive prostate cancer (nmHSPC) with “BCRAness” genotype (ROAR)
Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.364-364
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
ENCORE: A phase 2 trial of enfortumab vedotin (EV) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.TPS294-TPS294
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Correlation of age and the tumor transcriptomic profile in patients (pts) with advanced prostate cancer (PCa)
Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.233-233
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
AtezoCab: A phase II study of cabozantinib (C) in combination with atezolizumab (A) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with non-measurable disease (NMD)
Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.TPS295-TPS295
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Plasma circulating tumor DNA (ctDNA) based clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC)
Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.160-160
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
TROP-2 co-expression with androgen receptor splice variants as a new therapeutic target in prostate cancer
Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5060-5060
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Exosomal miR-1290 as a predictive biomarker for docetaxel response in metastatic castration resistant prostate cancer (mCRPC)
Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e16596-e16596
2016
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Randomized phase II trial of radium-223 (RA) plus enzalutamide (EZ) versus EZ alone in metastatic castration-refractory prostate cancer (mCRPC): Final efficacy and safety results
Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.135-135
2021
Volltextzugriff (PDF)
1 – 25 von 139
Suche als RSS-Feed
Aktive Filter
ThemaAdult
Zeitschrift / SerieJournal Of Clinical Oncology
Suchergebnisse filtern
Filter anzeigen